Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression-论文-万方医学网

首页> > Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

导出原文传递

翻译打印收藏纠错

第一作者： Anthony J. Rothschild

作者： Anthony J. Rothschild ^[1] ; Sagar V. Parikh ; Daniel Hain ; Rebecca Law ; Michael E. Thase ; Boadie W. Dunlop ; Charles DeBattista ; Charles R. Conway ; Brent P. Forester ; Richard C. Shelton ; Matthew Macaluso ; Krystal Brown ; David Lewis ; Alexer Gutin ; Michael R. Jablonski ; John F. Greden

作者单位： University of Massachusetts Medical School and UMass Memorial Healthcare, Worcester, MA 01655 ^[1]

关键词 GeneSight Combinatorial pharmacogenomics Pharmacokinetics CPIC guidelines Clinical validity Medication blood levels Depression

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

相似文献

同项目论文

相关期刊

检索历史 清除

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

相似文献

同项目论文

相关期刊

检索历史清除